Diabetes and the nervous system

Endocrinology and Metabolism Clinics of North America

Volumn 25, Issue 2, 1996, Pages 325-359

  Harati, Y ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 4 (METHYLSULFONYL)BUTYRYLGLUTAMYLHISTIDYLPHENYLALANYL DEXTRO LYSYLPHENYLALANINE; ALDOSE REDUCTASE INHIBITOR; GAMMA LINOLENIC ACID; GANGLIOSIDE; GLUCOSE TRANSPORTER; GROWTH FACTOR; INOSITOL; LACTIC ACID; LEVACECARNINE; THIOCTIC ACID;

BRAIN DISEASE; CEREBROVASCULAR DISEASE; DIABETES MELLITUS; DIABETIC COMA; DIABETIC NEUROPATHY; DIET SUPPLEMENTATION; HYPERGLYCEMIA; HYPEROSMOLAR COMA; KETOACIDOSIS; LACTIC ACIDOSIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STROKE;

EID: 0029929238     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(05)70327-3     Document Type: Article

References (299)

1. R.D. Abbot R.P. Donahue S.W. MacMahon Diabetes and the risk of stroke: The Honolulu Heart Program JAMA 257 1987 949 952
2. M.P. Abbracchio M. Di Luca A.M. Di Giulio Denervation and hyperinnervation in the nervous system of diabetic animals. III. Functional alternations of G proteins in diabetic encephalopathy J Neurosci Res 24 1989 517 523
3. R. Anghinah A.S. Oliveira A.A. Gabbai Effect of baclofen on pain in diabetic neuropathy Muscle Nerve 17 1994 958 959
4. A.G. Archer P.J. Watkins P.K. Thomas The natural history of acute painful neuropathy in diabetes mellitus J Neurol Neurosurg Psychiatry 46 1983 491 499
5. S.L. Atkin A.M. Coady D. Horton Multiple cerebral hematomata and peripheral nerve palsies associated with a case of juvenile diabetic ketoacidosis Diabetic Med 12 1995 267 270
6. V.L. Atluru Spontaneous intracerebral hematomas in juvenile diabetic ketoacidosis Pediatr Neurol 2 1986 167 169
7. R.N. Auer B.M. Siesjo Biological differences between ischemia, hypoglycemia, and epilepsy Ann Neurol 24 1988 699 707
8. R.N. Auer T. Wieloch Y. Olsson The distribution of hypoglycemic brain damage Acta Neuropathol (Berlin) 64 1984 177 191
9. R.N. Auer Progress review: Hypoglycemic brain damage Stroke 17 1986 699 708
10. R. Bacala K.J. Tracy A. Cerami Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilation in experimental diabetes J Clin Invest 87 1991 432 438
11. R.J. Barohn Z. Sahenk J.R. Warmolts The Bruns-Garland syndrome (diabetic amyotrophy) Arch Neurol 48 1990 1130
12. J.W. Baynes Role of oxidative stress in the development of complications in diabetes Diabetes 40 1991 405 412
13. D.S.H. Bell Stroke in the diabetic patient Diabetes Care 17 1994 213 218
14. F. Bellavere I. Balzani G. De Masi Power spectral analysis of heart-rate variations improves assessment of diabetic cardiac autonomic neuropathy Diabetes 41 1992 633 640
15. F. Bellavere G. Bosello C. Cardone Evidence of early impairment of parasympathetic reflexes in insulin dependent diabetics without autonomic symptoms Diabetes Metab 11 1985 152 156
16. L. Berger A.M. Hakim The association of hyperglycemia with cerebral edema in stroke Stroke 17 1986 865 871
17. L. Berger A.M. Hakim Nimodipine prevents hyperglycemia-induced cerebral acidosis in middle cerebral artery occluded rats J Cereb Blood Flow Metab 9 1989 58 64
18. G.J. Biessels A.C. Kappelle B. Bravenboer Cerebral function in diabetes mellitus Diabetologia 37 1994 643 650
19. J. Biller B.B. Love Diabetes and stroke Med Clin North Am 77 1993 71 79
20. J.D. Blackman V.L. Towle J. Sturis Hypoglycemic thresholds for cognitive dysfunction in IDDM Diabetes 41 1992 392 399
21. A.J. Boulton End-stage complications of diabetic neuropathy: Foot ulceration Can J Neurol Sci 21 1994 S18 S22
22. A.J.M. Boulton E. Anguis D.R. Ayyer Diabetic thoracic polyradiculopathy presenting as an abdominal swelling BMJ 289 1984 798 799
23. A.J.M. Boulton S. Levin J. Comstock A multicentre trial of the aldose reductase inhibitor tolrestat in patients with symptomatic neuropathy Diabetologia 33 1990 431
24. W.G. Bradley Critical review of ganglioside and thyrotropin-releasing hormone in peripheral neuromuscular diseases Muscle Nerve 13 1990 8333
25. B.A. Bravenboer A.C. Kapelle F.P.T. Hamers Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat Diabetologia 35 1992 813 817
26. B. Bravendoer P.H. Hendrikse P.L. Oey Randomized double-blind placebo-controlled trial to evaluate the effect of the ACTH4-9 analogue ORG 1766 in IDDM patients with neuropathy Diabetologia 37 1994 408 413
27. W.F. Brewster P. Fernyhough L.T. Diemel Diabetic neuropathy, nerve growth factor and other neurotrophic factors Trends Neurosci 17 1994 321 325
28. J.B. Brierley A.W. Brown B.S. Meldrum The time courses of ischeamic neuronal changes in the primate brain following profound arterial hypotension, air embolism and hypoglycaemia J Physiol 207 1970 59 60P
29. R.G. Browning D.W. Olson H.A. Stueven 50% Dextrose: Antidote or toxin? Ann Emerg Med 19 1990 683 687
30. M. Brownlee A. Cerami H. Vellassara Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications N Engl J Med 318 1988 1315 1321
31. M. Brownlee Glycation and diabetic complications Diabetes 43 1994 836 841
32. M. Brownlee Glycation products and the pathogenesis of diabetic complications Diabetes Care 15 1992 1835 1843
33. S.H. Buck T.F. Bucks The neuropharmacology of capsaicin: Review of some recent observations Pharmacol Rev 38 1986 179
34. E. Busse G. Zimmer B. Schopohl Influence of α-lipoic acid on intracellular glutathione in vitro and in vivo Arzneimittelforschung 42 1992 829 831
35. +-ATPase activity in galactose-fed mice Diabetes 39 1990 663
36. N.E. Cameron M.A. Cotter V. Archibald Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats Diabetologia 37 1994 449 459
37. N.E. Cameron M.A. Cotter K. Dines Effects of aminoguandine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats Diabetologia 35 1992 946 950
38. N.E. Cameron M.A. Cotter K.C. Dines Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: Dose-response considerations and independence from a myo-inositol mechanism Diabetologia 37 1994 651 663
39. N.E. Cameron M.A. Cotter E.K. Maxifield Antioxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats Diabetologia 36 1993 299 304
40. N.E. Cameron M.A. Cotter Neurovascular dysfunction in diabetic rats J Clin Invest 96 1995 1159 1163
41. N.E. Cameron M.A. Cotter The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications Diabetes Metab Rev 10 1994 189 224
42. N.E. Cameron K.C. Dines M.A. Cotter The potential contribution of endothelin-1 to neurovascular abnormalities in streptozotocin-diabetic rats Diabetologia 37 1994 1209 1215
43. Capsaicin Study Group Effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy Diabetes Care 15 1992 159
44. B.L. Carter R.E. Small M.D. Mandel Phenytoin-induced hyperglycemia Am J Hosp Pharm 38 1981 1508 1512
45. P.R. Cavanagh M.J. Young J.E. Adams Radiographic abnormalities in diabetic feet A.J.M. Boulton H. Connor P.R. Cavanaugh The Foot in Diabetes 1994 Wiley Chichester 165 176
46. A.K. Chakrabarti S.K. Samantary Diabetic peripheral neuropathy: Nerve conduction studies before, during, and after carbamazepine therapy Aust NZ Med 6 1976 565
47. D.W. Choi Methods for antagonizing glutamate neurotoxicity Cerebrovasc Brain Metab Rev 2 1990 105 147
48. S.W. Coppack P.J. Watkins The natural history of diabetic amyotrophy Q J Med 79 1991 307
49. D.R. Cornblath D.B. Drachman J.W. Griffin Demyelinating motor neuropathy in patients with diabetic polyneuropathy Ann Neurol 22 1989 126
50. B.M. Coull N. Beamer P. de Garmo Chronic blood hyperviscosity in subjects with acute stroke, transient ischemic attack, and risk factors for stroke Stroke 22 1991 162 168
51. N.H. Cox J.W. Lorains The prognostic value of blood glucose and glycosylated hemoglobin estimation in patients with stroke Postgrad Med J 62 1986 7 10
52. S.M. Crain Neurotropic factors in diabetic neuropathy Trends Neurosci 18 1995 15 16
53. C.L. Crawford M.J. Hobbs Neurotrophic factors in diabetic neuropathy Trends Neurosci 18 1995 15 16
54. G. Crepaldi D. Fedele A. Tiengo Ganglioside treatment in diabetic peripheral neuropathy: A multicenter trial Acta Diabetol Lat 10 1983 265
55. N. Croughwell N. Lyth T.J. Quill Diabetic patients have abnormal cerebral autoregulation during cardiopulmonary bypass Circulation 82 1990 IV407 IV412
56. N.A. Cullum J. Mahon K. Stringer Glycation of rat sciatic nerve tubulin in experimental diabetes mellitus Diabetologia 34 1991 387
57. J.T. Daugirdas N.O. Kronfol A.H. Tzamaloukas Hyperosmolar coma: Cellular dehydration and the serum sodium concentration Ann Intern Med 110 1989 855 857
58. Courten de G. Meyers R.E. Meyers Hyperglycemia enlarges infarct size in cerebrovascular occlusion in cats Stroke 19 1988 623 630
59. J.E. Deanfield P.R. Daggrett M.J. Harrison The role of autonomic neuropathy in diabetic foot ulceration J Neurol Sci 47 1980 103 110
60. P. DeFeo V. Gallai A. Maxxotta Modest decrement in plasma glucose concentrations cause early impairment in cognitive function and late activation of glucose counterregulation in the absence of hypoglycemic symptoms in normal man J Clin Invest 82 1988 436 444
61. A. Dejgaard A. Gade H. Larsson Evidence for diabetic encephalopathy Diabetic Med 8 1991 162 167
62. A. Dejgaard P. Petersen J. Kastrup Mexiletine for treatment of chronic painful diabetic neuropathy Lancet 1 1988 9
63. A.M. Di Giulio E. Lesma A. Gorio Diabetic neuropathy in the rat. 1. Alcar augments the reduced levels and axoplasmic transport of substance P J Neurosci Res 40 1995 414 419
64. Diabetes Control and Complications Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 1993 977 986
65. D.G. Dills S.E. Moss R. Klein Association of elevated IGF-1 levels with increased retinopathy in late-onset diabetes Diabetes 40 1991 1725 1730
66. K.C. Dines M.A. Cotter N.E. Cameron Contrasting effects of treatment with omega-3 and omega-6 essential fatty acids on peripheral nerve function and capillarization in streptozotocin-diabetic rats Diabetologia 36 1993 1132 1183
67. R.B. Duckrow D.C. Beard R.W. Brennan Regional cerebral blood flow decreases during chronic and acute hyperglycemia Stroke 18 1987 52 58
68. R.B. Duckrow R.M. Bryan Jr Regional cerebral glucose utilization during hyperglycemia J Neurochem 48 1987 989 993
69. R.B. Duckrow Glucose transfer into rat brain during acute and chronic hyperglycemia Metab Brain Dis 3 1988 201 209
70. J.S. Duker B.C. Brown T.M. Bosley Asymmetric proliferative diabetic retinopathy and carotid artery disease Ophthalmology 21 1990 869 874
71. J.A. Durr W.H. Hoffman A.H. Sklar Correlates of brain edema in uncontrolled IDDM Diabetes 41 1992 627 632
72. D. Duverger E.T. MacKenzie The quantification of cerebral infarction following focal ischemia in the rat: Influence of strain, arterial pressure, blood glucose concentration, and age J Cereb Blood Flow Metab 8 1988 449 461
73. P.J. Dyck S. Hansen J. Karnes Capillary number and percentage closed in human diabetic sural nerve Proc Natl Acad Sci USA 82 1985 2513
74. P.J. Dyck J.L. Karnes P. O'Brien The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemia Ann Neurol 19 1986 440
75. P.J. Dyck J.L. Karnes P.C. O'Brien The Rochester Diabetic Neuropathy Study: Reassessment of tests and criteria for diagnosis and staged severity Neurology 42 1992 1164 1170
76. P.J. Dyck K.M. Kratz M.S. Karnes The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: The Rochester Diabetic Neuropathy Study Neurology 43 1993 817 824
77. P.J. Dyck P.C. O'Brien Meaningful degrees of prevention or improvement of nerve conduction in controlled clinical trials of diabetic neuropathy Diabetes Care 12 1989 649
78. P.J. Dyck R.B. Zimmerman T.H. Vilen Nerve glucose, fructose, sorbitol, myo-inositol and fiber degeneration and regeneration in diabetic neuropathy N Engl J Med 319 1988 542 548
79. D. Edelstein M. Brownlee Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine Diabetes 41 1991 26
80. M. Ellenberg Diabetic neuropathic cachexia Diabetes 23 1974 418
81. M. Ellenberg Treatment of diabetic neuropathy with diphenylhydantoin NY State Med J 68 1968 2653
82. R.L. Engerman T.S. Kern M.E. Larson Nerve conduction and aldose reductase inhibition during 5 years of diabetes of galactosemia in dogs Diabetologia 37 1994 141 144
83. V. Faradji J. Sotelo Low serum levels of nerve growth factor in diabetic neuropathy Acta Neurol Scand 81 1990 402
84. C.M. Florkowski B.R. Rowe S. Nightingale Clinical and neurophysiological studies of aldose reductase inhibitor ponalrestat in chronic symptomatic diabetic peripheral neuropathy Diabetes 40 1991 129 133
85. M. Franceschi R. Cecchetto F. Minicucci Cognitive processes in insulin-dependent diabetes Diabetes Care 7 1984 228 231
86. D.M. Fraser I.W. Campbell D.J. Ewing Peripheral and autonomic nerve function in newly diagnosed diabetes mellitus Diabetes 26 1977 546 550
87. W.A. Frazier R. Hogue-Angeletti R.A. Bradshaw Nerve growth factor and insulin, structural similarities indicate an evolutionary relationship reflected by physiological action Science 76 1972 482
88. L.G. Futterman L. Lemberg Heart rate variability. Prognostic implications Am J Crit Care 3 1994 476 480
89. L. Ganzini R.T. Heintz W.F. Hoffman The relevance of tardive dyskinesia in neuroleptic-treated diabetics: A controlled study Arch Gen Psychiatry 48 1991 259 263
90. C. Giannini P.J. Dyck Ultrastructural morphometric abnormalities of sural nerve endoneurial microvessels in diabetes mellitus Ann Neurol 36 1994 408 415
91. Giannini C, Dyck PJ: Nodal axoglial dysjunction. J of EMT, in press
92. C. Giannini P.J. Dyck Basement membrane reduplication and pericyte degeneration precede development of diabetic polyneuropathy and are associated with its severity Ann Neurol 37 1995 498 504
93. R.G. Giffard H. Monyer D.W. Choi Selective vulnerability of cultured cortical glia to injury by extracellular acidosis Brain Res 530 1990 139 141
94. M.D. Ginsberg R. Busto Rodent models of cerebral ischemia Stroke 20 1989 1627 1642
95. A. Gjedde C. Crone Blood-brain glucose transfer: Repression in chronic hyperglycemia Science 214 1981 456 457
96. A. Gjedde E. Siemkowicz Effect of glucose and insulin pretreatment on cerebral metabolic recovery after ischemia Trans Am Neurol Assoc 103 1978 45 47
97. A.H. Glassman S.P. Roose J.T. Bigger Jr The safety of tricyclic antidepressants in cardiac patients JAMA 269 1993 2673
98. Y. Goto N. Oikawa Y. Akanuma Clinical study of a new aldose reductase inhibitor (ONO-2234) on diabetic neuropathy—a multicenter study J Jpn Diabetes Soc 28 1985 89
99. E. Granieri I. Casetta Govoni et al: Gangliosides therapy and Guillain-Barre syndrome Neuroepidemiology 10 1991 161
100. M. Grant B. Russell C. Fitzgerald Insulin-like growth factors in vitreous: Studies in control and diabetic subjects with neovascularization Diabetes 35 1986 416 420
101. C.S. Gray J.M. French D. Bates Increasing age, diabetes mellitus, and recovery from stroke Postgrad Med J 65 1989 720 724
102. D.A. Greene A.A.F. Sima M.J. Stevens Complications: Neuropathy, pathogenetic considerations Diabetic Care 15 1992 1902 1925
103. G. Gregersen H. Borsting P. Theil Myoinositol and function of peripheral nerve in human diabetes: A controlled clinical trial Acta Neurol Scand 58 1978 241
104. D.N. Griffith S. Saimbi C. Lewis Abnormal cerebrovascular carbon dioxide reactivity in people with diabetes Diabetic Med 4 1987 217 220
105. R. Guisado A.L. Arieff Neurologic manifestations of diabetic comas: Correlations with biochemical alterations in the brain Metabolism 24 1975 665 679
106. M. Gutniak G. Blomquist L. Widen D-[U-11C]glucose uptake and metabolism in the brain of insulin-dependent diabetic subjects Am J Physiol 258 1990 E805 E812
107. L.L. Haheim I. Holme I. Hjermann Nonfasting serum glucose and the risk of fatal stroke in diabetic and nondiabetic subjects: 18-year follow-up of the Oslo study Stroke 26 1995 774 777
108. M. Hallett T. Flood N. Slater Trial of ganglioside therapy for diabetic neuropathy Muscle Nerve 10 1987 822
109. M.G. Hamilton B.I. Tranmer R.N. Auer Insulin reduction of cerebral infarction due to transient focal ischemia J Neurosurg 82 1995 262 268
110. M.R. Hammerman S.B. Miller Renal cellular biology of growth hormone and insulin-like growth factor 1 Pediatr Nephrol 5 1991 505 508
111. H.P. Hammes S. Martin K. Federlin Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy [abstract] Diabetes 39 suppl 1 1990 62A
112. Y. Harati P.A. Low Autonomic peripheral neuropathies: Diagnosis and clinical presentation S.H. Appel Current Neurology 1990 Mosby-Year Book Chicago 105
113. Y. Harati E. Niakan Diabetic thoracoabdominal neuropathy: A cause for chest and abdominal pain Arch Intern Med 146 1986 1493
114. Y. Harati Diabetic peripheral neuropathies Ann Intern Med 107 1987 546
115. Y. Harati Frequently asked questions about diabetic peripheral neuropathies Neurol Clin 10 1992 783 807
116. R.J. Harris T. Wieloch L. Symon Cerebral extracellular calcium activity in severe hypoglycemia: Relation to extracellular, potassium and energy state J Cereb Blood Flow Metab 4 1984 187 193
117. C.M. Helgason Blood glucose and stroke Stroke 19 1988 1049 1053
118. R. Hellweg H.D. Hartung Endogenous levels of nerve growth factor are altered in experimental diabetes mellitus: A possible role for NGF in the pathogenesis of diabetic neuropathy J Neurosci Res 26 1990 258
119. R. Hellweg G. Raivich H.D. Hartung Axonal transport of endogenous nerve growth factor (NGF) and NGF receptor in experimental diabetic neuropathy Exp Neurol 130 1994 24 30
120. R.C. Hennebery Commentary: The role of neuronal energy in the neurotoxicity of excitatory amino acids Neurobiol Aging 10 1989 611 613
121. + ATPase activity in sciatic nerve of diabetic mice by administration of H7 or Calphostin C, inhibitors of PKC Diabetes 42 1993 257 262
122. W.H. Hoffman C.M. Steinhart T. El Gammal Cranial computed tomography in children and adolescents with diabetic ketoacidosis J Neuroradiol 9 1988 733 739
123. C.S. Holmes K.M. Koepke R.G. Thompson Verbal fluency and naming performance in type 1 diabetes at different blood glucose concentrations Diabetes Care 7 1984 454 459
124. C.S. Holmes L.C. Richman Cognitive profiles of children with insulin-dependent diabetes J Dev Behav Pediatr 6 1985 323 326
125. C.S. Holmes Neuropsychological profiles in men with insulin-dependent diabetes J Consult Clin Psychol 54 1986 386 389
126. H.C. Hopf L. Gutmann Diabetic 3rd nerve palsy: Evidence for a mesencephalic lesion Neurology 40 1990 1041 1045
127. Y. Ido J. McHowat K. Change Neural dysfunction and metabolic imbalances in diabetic rats: Prevention by acetyl-L-carnitine Diabetes 43 1994 1469 1477
128. S. Ishibashi N. Mori M. Shimada Apolipoprotein E: Metabolism in sciatic nerves of diabetic rats Horm Metab Res 25 1993 82 87
129. D.N. Ishii Implication of insulin-like growth factors in the pathogenesis of diabetic neuropathy Brain Res Brain Res Rev 20 1995 47 67
130. J. Jakobsen M. Nedergaard M. Aarslew-Jensen Regional brain glucose metabolism and blood flow in streptozocin-induced diabetic rats Diabetes 39 1990 437 440
131. J. Jaspan J. Maloe T. Nikolai Clinical response to sorbinil in painful diabetic neuropathy Diabetes 38 1989 14A
132. P.C. Johnson K. Brendel E. Meezan Thickened cerebral cortical capillary basement membranes in diabetics Arch Pathol Lab Med 106 1982 214 217
133. P.C. Johnson S.C. Doll D.W. Cromey Pathogenesis of diabetic neuropathy Ann Neurol 19 1986 450
134. T.W. Jones G. McCarthy W.V. Tamborlane Mild hypoglycemia and impairment of brain stem and cortical evoked potentials in healthy subjects Diabetes 39 1990 1550 1555
135. J. Kastrup H.R. Angelo P. Petersen Treatment of chronic painful diabetic neuropathy with intravenous lidocaine infusion BMJ 292 1986 173
136. J. Kastrup S. Rrsgaard H.H. Parving Impaired autoregulation of cerebral blood flow in long-term type 1 (insulin-dependent) diabetic patients with nephropathy and retinopathy Clin Physiol 6 1986 549 559
137. H. Keen J. Payan J. Allawi Treatment of diabetic neuropathy with gammalinolenic acid Diabetes Care 16 1993 8 15
138. P. Kempler A. Veradi F. Szalay Autonomic neuropathy and corrected QT interval prolongation: There is a relationship Diabetes Care 17 1994 454 456
139. W.R. Kennedy X. Navarro F.C. Goetz Effects of pancreatic transplantation on diabetic neuropathy N Engl J Med 322 1990 1031
140. W. Kern W. Kerner R. Pietrowsky Effect of insulin and hypoglycemia on the auditory brain stem response in humans J Neurophysiol 72 1994 678 683
141. M. Kihara P.A. Low Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathy Exp Neurol 132 1995 180 185
142. M.J. Kihara J.D. Schmelzer J.F. Poduslo Aminoguanidine effect on nerve blood flow vascular permeability, electrophysiology, and oxygen free radicals Proc Natl Acad Sci USA 88 1991 6107 6111
143. M.P. Kihara P.J. Zollman I.L. Smithson Hypoxic effect of exogenous insulin on normal and diabetic peripheral nerve Am J Physiol 266 1994 E980 E985
144. T.S. King D.H. Rohrach Reduced aminergic synthesis in the hypothalamus of the hypothalamus of the infertile, genetically diabetic (C57BL/KsJ-db/db) male mouse Exp Res 81 1990 619 625
145. J.Y. Koh M.P. Goldberg D.M. Hartley Non-NMDA receptor mediated neurotoxicity in cortical culture J Neurosci 10 1990 693 705
146. E.J. Krane M.A. Rockoff J.K. Wallman Subclinical brain swelling in children during treatment of diabetic ketoacidosis N Engl J Med 312 1985 1147 1151
147. M. Krushner P. Nencini M. Reivich Relation of hyperglycemia early in ischemic brain infarction to cerebral anatomy, metabolism, and clinical outcome Ann Neurol 28 1990 129 135
148. L.H. Kuller J.S. Dorman P.A. Wolf Cerebrovascular disease and diabetes M.I. Harris R.F. Hamman Diabetes in America—Diabetes Data Compiled 1984 1985 US Department of Health and Human Services Bethesda, MD 18-1-18-18, 18-1-18-18
149. S. Kumar H.A. Ashe L.N. Parnell The prevalence of foot ulceration and its correlates in type 2 diabetic patients. A population-based study Diabetic Med 11 1994 480 484
150. H. Kuzuya N. Matsuura M. Sakamoto Trial of insulinlike growth factor 1 therapy for patients with extreme insulin resistance syndromes Diabetes 42 1993 696 705
151. Z. Lackovic M. Salkovic Z. Kuchi Effect of long-lasting diabetes mellitus on rat and human brain monoamines J Neurochemistry 54 1990 143 147
152. J.C. LaManna S.I. Harik Regional comparisons of brain glucose influx Brain Res 326 1985 299 305
153. S.J. Langan I.J. Deary D.A. Hepburn Cumulative cognitive impairment following recurrent severe hypoglycemia in adult patients with insulin-treated diabetes mellitus Diabetologia 34 1991 337 344
154. J.G. Llewelyn S.G. Gilbey P.K. Thomas Sural nerve morphometry in diabetic autonomic and painful sensory neuropathy Brain 114 1991 867
155. J.G. Llewelyn S.G. Gilbey P.K. Thomas Sural nerve morphometry in diabetic autonomic and painful sensory neuropathy: A clinicopathological study Brain 114 1991 867 892
156. P.A. Low T.D. Langerlund P.G. McManis Nerve blood flow and oxygen delivery in normal diabetic and ischemic neuropathy Int Rev Neurobiol 31 1989 355
157. P.A. Low K.K. Nickander Oxygen free radical effects in sciatic nerve in experimental diabetes Diabetes 40 1991 873 877
158. Low PA, Opfer-Gehrking TL, Dyck PJ, et al: Double-blind, placebo-controlled study of the application of capsaicin creams in chronic distal painful polyneuropathy. Pain, in press
159. P.A. Low Recent advances in the pathogenesis of diabetic neuropathy Muscle Nerve 10 1987 121 128
160. S. Lowitt J.I. Malone A.F. Salem Acetyl-L-carnitine corrects the altered peripheral nerve function of experimental diabetes Metabolism 44 1995 677 680
161. M. Lunetta A.R. Damanti G. Fabbri Evidence by magnetic resonance imaging of cerebral alterations of atrophy type of young insulin-dependent diabetic patients J Endocrinol Invest 17 1994 241 245
162. A.F. Macleod A.J.M. Boulton D.R. Owens A multicenter trial of the aldose reductase inhibitor tolrestat in patients with symptomatic diabetic peripheral neuropathy Diabete Metab 18 1992 14 20
163. R. Malik S. Tesfaye S.D. Thompson Transperineurial capillary abnormalities in the sural nerve of patients with diabetic neuropathy Microvasc Res 48 1994 236 245
164. R.A. Malik S. Kumar A.J. Boulton Mendenhall's syndrome: Clues to the etiology of human diabetic neuropathy J Neurol Neurosurg Psychiatry 58 1995 493 495
165. R.A. Malik E.A. Masson A.K. Sharma Hypoxic neuropathy: Relevance to human diabetic neuropathy Diabetologia 33 1990 311
166. J.I. Malone S. Lowitt N. Corsico Altered neuroexcitability in experimental diabetic neuropathy: Effect of acetyl-L-carnitine Int J Clin Pharmacol Res 12 1992 237 241
167. R. Malouf J.C. Brust Hypoglycemia: Causes, neurological manifestations, and outcome Ann Neurol 17 1985 421 430
168. R.E. Maser M.A. Pfeifer J.S. Dorman Diabetic autonomic neuropathy and cardiovascular risk: Pittsburgh Epidemiology of Diabetes Complications Study III Arch Intern Med 150 1990 1218 1222
169. M.B. Max M. Culnane S.C. Schafer Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood Neurology 37 1987 589
170. M.B. Max R. Koshor-Kumar S.C. Schafer Efficacy of desipramine in painful diabetic neuropathy: A placebo-controlled trial Pain 54 1991 3
171. M.B. Max S.A. Lynch J. Muir Effects of desipramine, amitriptyline, and fluoxetine of pain in diabetic neuropathy N Engl J Med 326 1992 1250 1256
172. J. McAloon D. Carson P. Crean Cerebral oedema complicating diabetic ketoacidosis Acta Paediatr Scand 79 1990 115 117
173. A.L. McCall L.B. Fixman N. Flemming Chronic hypoglycemia increases brain glucose transport Am J Physiol 251 1986 E442 E447
174. A.L. McCall Brain microvascular transport and metabolism: Implications for diabetes N.B. Ruderman M. Brownlee J. Williamson Hyperglycemia and Vascular Disease 1992 Oxford University Press London
175. A.L. McCall Perspectives in diabetes: The impact of diabetes on the CNS Diabetes 41 1992 557 570
176. D.K. McCulloch I.W. Campbell R.J. Prescott Effects of alcohol intake on symptomatic peripheral neuropathy in diabetic men Diabetes Care 3 1980 245
177. M.J. McNeely E.J. Boyko J.H. Ahroni The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration: How great are the risks? Diabetes Care 18 1995 216 219
178. A.D. Merry M. Kamijo S.A. Lattimer Long-term prevention and intervention effects of acetyl-L-carnitine on diabetic neuropathy [abstract] Diabetes 43 suppl 1 1994 108A
179. A. Moglia R. Lorini G. D'Annunzio Clinical and neurophysiological study in diabetic children and adolescents Funct Neurol 9 1994 75 82
180. A.D. Mooradiam A.M. Morin Brain uptake of glucose in diabetes mellitus: The role of glucose transporters Am J Med Sci 301 1991 173 177
181. A.D. Mooradian Diabetic complications of the central nervous system Endocr Rev 9 1988 346 356
182. S. Mukherjee S. Roth R. Sandyk Persistent tardive dyskinesias and neuroleptic effects on glucose tolerance Psychiatry Res 29 1989 17 27
183. S. Mukherjee A. Wisniewski R. Bilder Possible association between tardive dyskinesia and altered carbohydrate metabolism Arch Gen Psychiatry 42 1985 205
184. M. Nagamatsu K.K. Nickander J.D. Schmelzer Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy Diabetes Care 18 1995 1150 1167
185. C.V. Natraj V.M. Gandhi K.K.G. Menon Lipoic acid and diabetes: Effect of dihydrolipoic acid administration in diabetic rats and rabbits J Biosci 6 1984 37 46
186. M. Nedergaard N.H. Diemer Focal ischemia of the rat brain, with special reference to the influence of plasma glucose concentration Acta Neuropathol 73 1987 131 137
187. C. Neumann L. Branchtein H. Schmid Severe autonomic neuropathy: How many symptoms? Diabetes Care 18 1995 133 134
188. P.G. Newrick A.J. Wilson J. Jakubowski Sural nerve oxygen tension in diabetes BMJ 293 1986 1053
189. E. Niakan Y. Harati J.P. Comstock Diabetic autonomic neuropathy Metabolism 35 1986 244
190. K. Nicholls T.E. Mandel Advanced glycosylation end-products in experimental murine diabetic nephropathy: Effect of islet isografting and of aminoguanidine Lab Invest 60 1989 486
191. I.A. O'Brien J.P. McFadden R.J.M. Corral The influence of autonomic neuropathy on mortality in insulin dependent diabetes Q J Med 79 1991 495
192. O.E. Owen A.P. Morgan H.G. Kemp Brain metabolism during fasting J Clin Invest 46 1967 1589 1595
193. D.S. Owens D. Benton The impact of raising blood glucose on reaction times Neuropsychology 30 1994 106 113
194. P.J. Palumbo L.R. Elvebak J.P. Whisnant Neurologic complications of diabetes mellitus: Transient ischemic attacks as opposed to strokes Eur J Vasc Surg 1 1987 259 262
195. M.P. Papagapiou R.N. Auer Regional neuroprotective effects of the NMDA receptor antagonist MK-801 (dizocilpine) in hypoglycemic brain damage J Cereb Blood Flow Metab 10 1990 270 276
196. W.M. Pardridge D. Triguero C.R. Farrel Downregulation of blood-brain barrier glucose transporter in experimental diabetes Diabetes 39 1990 1040 1044
197. N.A. Parfrey Improved diagnosis and prognosis of mucormycosis: A clinicopathologic study of 33 cases Medicine 65 1986 113 123
198. A.W. Patrick I.W. Campbell Fatal hypoglyceamia in insulin-treated diabetes mellitus: Clinical features and neuropathological changes Diabetic Med 1990 340 354
199. D. Pelligrino B.K. Siesjo Regulation of extra- and intracellular pH in the brain in severe hypoglycemia J Cereb Blood Flow Metab 1 1981 85 96
200. D.A. Pelligrino L.J. Segil R.F. Albrecht Brain glucose utilization and transport and cortical function in chronic vs. acute hypoglycemia Am J Physiol 259 1990 E729 E735
201. D.B. Petitti H. Bhatt Retinopathy as a risk factor for nonembolic stroke in diabetic subjects Stroke 26 1995 593 596
202. S. Picard S. Parthasarathy J. Fruebis Aminoguandine inhibits oxidative modification of low density lipoprotein protein and the subsequent increase in uptake by the macrophage scavenger receptor Proc Natl Acad Sci USA 89 1992 6876 6880
203. S. Podolsky N.A. Leopold D.S. Sax Increased frequency of diabetes mellitus in patients with Huntington's chorea Lancet 1972 1356 1359
204. G. Pozzessere V. Elvira S. DeGrignis Abnormalities of cognitive functions in IDDM revealed by P300 event-related potential analysis Diabetes 40 1991 952 958
205. W. Pulsinelli D.E. Levy B. Sigsbee Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus Am J Med 74 1983 540 543
206. W. Pulsinelli S. Waldman B. Sigsbee Experimental hyperglycemia and diabetes mellitus worsen stroke outcome Trans Am Neurol Assoc 105 1980 21 24
207. W.A. Pulsinelli S. Waldman D. Rawlinson Moderate hyperglycemia augments ischemic brain damage: A neuropathologic study in the rat Neurology 32 1982 1239 1246
208. T.S. Purewal P.J. Watkins Postural hypotension in diabetic autonomic neuropathy: A review Diabetic Med 12 1995 192 200
209. A. Quatraro A. Minei N. DeRosa Calcitonin in painful diabetic neuropathy Lancet 339 1992 746 747
210. A. Quatraro P. Roca C. Donzella Acetyl-L-carnitine for symptomatic diabetic neuropathy Diabetologia 38 1995 123
211. Z. Ram M. Sadeh R. Walden Vascular insufficiency quantitatively aggravates diabetic neuropathy Arch Neurol 48 1991 1239
212. C. Rask S. Apfel D. Adornato An overview of the clinical experience with systemic administration of nerve growth factor in treating peripheral nervous system disorders Ann Neurol 38 1995 317
213. G.M. Reaven L.W. Thompson D. Nahurn Relationship between hyperglycemic and cognitive function in older NIDDM patients Diabetes Care 13 1990 16 21
214. S. Rehncrona I. Rosen B.K. Siesjo Brain lactic acidosis and ischemic cell damage I. Biochemistry and neurophysiology J Cereb Blood Flow Metab 1 1981 297 311
215. B. Reichard A. Britz S. Levander Intensified conventional insulin treatment and neuropsychological impairment BMJ 303 1991 1439 1442
216. P. Reichard B.Y. Nielsson U. Rosenquist The effect of long-term intensified insulin treatment on the development of microvascular complications or diabetes mellitus N Engl J Med 329 1993 304 309
217. E. Reissell A. Yli-Hankala R. Orko Sudden cardiorespiratory arrest after renal transplantation in a patient with diabetic autonomic neuropathy and prolonged QT interval Acta Aneasthesiol Scand 38 1994 406 408
218. M.C. Riddle J. Hart Hyperglycemia, recognized and unrecognized, as a risk factor for stroke and transient ischemic attacks Stroke 13 1982 356 359
219. G. Rodriguez F. Nobili M.A. Celestine Regional cerebral blood flow and cerebrovascular reactivity in IDDM Diabetes Care 16 1993 462 468
220. A.L. Rosenbloom Intracerebral crises during treatment of diabetic ketoacidosis Diabetes Care 13 1990 22 33
221. G. Rosoklija A.P. Hays N. Latov Proximal diabetic neuropathy: Immunological mechanisms Neurology 45 suppl 4 1995 A397
222. N.B. Ruderman S. Gupta I. Susmann Hyperglycemia, diabetes, and vascular disease: An overview N. Ruderman J. Williamson M. Brownlee Hyperglycemia, Diabetes and Vascular Disease 1992 Oxford University Press New York 3
223. N.B. Ruderman C.C. Haudenschild Diabetes as an atherogenic factor Prog Cardiovasc Dis 26 1984 373 412
224. J.A. Rull R. Quibrera H. Gonzalez-Millan Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (tegretol): Double-blind crossover trial Diabetologia 5 1969 215
225. C.N. Ryan T.M. Williams T.J. Orchard Psychomotor slowing is associated with distal symmetrical polyneuropathy in adults with diabetes mellitus Diabetes 41 1992 107 113
226. C. Ryle M. Donaghy Glycation of peripheral nerve proteins in diabetes mellitus J Neurol Sci 129 1995 62 68
227. G. Said C. Goulon-Goeau C. LaCroix Nerve biopsy findings in different patterns of proximal diabetic neuropathy Ann Neurol 35 1994 559 569
228. G. Said G. Slama J. Selva Progressive centripetal degeneration of axons in small fibre type diabetic polyneuropathy: A clinical and pathological study Brain 106 1983 791 807
229. 1 dopamine receptor in alloxan-induced diabetes Diabetes 41 1992 1119 1121
230. C.F. Saller L.A. Chiodo Glucose suppresses basal firing and haloperidol-induced increases in the firing rate of central dopaminergic neurons Science 210 1980 1269 1271
231. C.F. Saller I.J. Kopin Glucose potentiates haloperidol-induced catalepsy Life Sci 29 1981 2337 2341
232. R. Sandyk M.A. Gillman Tardive dyskinesia and glucose metabolism Arch Gen Psychiatry 43 1986 193
233. R. Sandyk S.R. Kay G.I. Awerbuch Risk factors for neuroleptic induced movement disorders Int J Neurosci 16 1991 149 188
234. R. Sandyk Increased incidence of neuroleptic-induced perioral movements in the rat by hyperglycemia Int J Neurosci 50 1990 227 232
235. R. Sandyk The relationship between diabetes mellitus and Parkinson's disease Int J Neurosci 69 1993 125 130
236. J.V. Santiago P.H. Sonksen A.J.M. Boulton Withdrawal of the aldose reductase inhibitor tolrestat in patients with diabetic neuropathy: Effect on nerve function J Diabetes Complications 7 1993 170 178
237. A. Sauter M. Goldstein J. Engel Effect of insulin on central catecholamines Brain Res 260 1983 330 333
238. Y. Schmidt J.W. Unger I. Bartke Effect of nerve growth factor on peptide neurons in dorsal root ganglia after taxol or cisplatin treatment and in diabetic (db/db) mice Exp Neurol 132 1995 16 23
239. J.H. Schoemaker Pharmacological treatment of diabetic peripheral neuropathy: Challenges and possibilities Br J Clin Pract 48 1994 91 96
240. J.F. Service Hypoglycemia Med Clin North Am 79 1995 1 8
241. A.K. Sharma P.K. Thomas Animal models: Pathology and pathophysiology P.J. Dyck P.K. Thomas A.K. Asbury Diabetic Neuropathy 1987 Saunders WB Philadelphia 237
242. E. Siemkowicz A. Gjedde Post-ischemic coma in rat: Effect of different pre-ischemic blood glucose levels on cerebral metabolic recovery after ischemia Acta Physiol Scand 110 1980 225 232
243. A.A. Sima D.A. Greene Diabetic neuropathy in the elderly Drugs Aging 6 1995 125 135
244. A.A. Sima S.A. Lattimer S. Yagihashi Axo-glial dysfunction: A novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic bio-breeding rat J Clin Invest 77 1986 474
245. A.A.F. Sima V. Bril V. Nathanial Regeneration and repair of myelinated fibers in sural nerve biopsies from patients with diabetic neuropathy treated with sorbinil, an investigational aldose reductase inhibitor N Engl J Med 319 1988 548
246. S. Singh R. Sandyk S.R. Kay Diabetes mellitus as a risk factor for neuroleptic-induced akathisia Neurology 40 suppl 1990 146
247. J.T. Sladky R.L. Tschoepe J.H. Greenberg Peripheral neuropathy after chronic endoneurial ischemia Ann Neurol 29 1991 272
248. M.L. Smith R. von Hanwehr B.K. Siesjo Changes in extra-and intracellular pH in the brain during and following ischemia in hyperglycemic and in moderately hypoglycemic rats J Cereb Blood Flow Metab 6 1986 574 583
249. Sorbinil Retinopathy Trial Research Group The Sorbinil Retinopathy Trail: Neuropathy results Neurology 43 1993 1141 1149
250. V.F. Sotelo Low serum levels of nerve growth factor in diabetic neuropathy Acta Neurol Scand 81 1990 402
251. T. Soulis-Liparata M. Cooper D. Papazoglou Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat Diabetes 40 1991 1328
252. +)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat J Clin Invest 94 1994 853 859
253. E.F. Stevens M.J. Lockett A.L. Carrington Essential fatty acid treatment prevents nerve ischemia and associated conduction anomalies in rats with experimental diabetes mellitus Diabetologia 36 1993 397 401
254. E.J. Stevens A.L. Carrington D.R. Tomlinson Nerve ischemia in diabetic rats: Time course of development effect of insulin treatment plus comparison of streptozotocin and B models Diabetologia 37 1994 43 48
255. J.D. Stewart Diabetic truncal neuropathy: Topography of the sensory deficit Ann Neurol 25 1989 233
256. R.D. Stout Insulin and atheroma: 20-year perspective Diabetes Care 13 1990 631 654
257. H. Stracke U.E. Meyer H.E. Schumacher Mexiletine in the treatment of diabetic neuropathy Diabetes Care 15 1992 1550 1555
258. A.M. Sugar Mucormycosis Clin Infect Dis 14 suppl 1 1992 S126 S129
259. K. Sugimura P.J. Dyck Multifocal fiber loss in proximal sciatic nerve in symmetric distal diabetic neuropathy J Neurol Sci 53 1982 501
260. G. Sundkvist F.M. Armstrong J.E. Bradbury Peripheral and autonomic nerve function in 259 diabetic patients with peripheral neuropathy treated with ponalrestat (an aldose reductase inhibitor) or placebo for 18 Months J Diabetes Complications 6 1992 123 130
261. A. Sunshine New clinical experience with Tramadol Drugs 47 suppl 1 1994 8 18
262. Y.J. Suzuki M. Tsuchiya L. Packer Thioctic acid and dihydrolipoic acid are novel antioxidants which interact with reactive oxygen species Free Radical Res Commun 15 1991 255 263
263. M. Swerdlow Review: Anticonvulsant drugs and chronic pain Clin Neuropharmacol 7 1984 51
264. Y.-M. Tan J. Croese Clonidine and diabetic patients with leg pains Ann Intern Med 105 1986 633
265. R. Tandan G.A. Lewis P.B. Krusinski Topical capsaicin in painful diabetic neuropathy Diabetes Care 15 1992 8
266. H. Taubin R. Matz Cerebral edema, diabetes insipidus, and sudden death during the treatment of diabetic ketoacidosis Diabetes 17 1968 108 109
267. G. Tesco S. Latorraca P. Piersanti Protection from oxygen radical damage in human diploid fibroblasts in acetyl-L-carnitine Dementia 3 1992 58 60
268. S. Tesfaye N. Harris R.M. Wilson Exercise induced conduction velocity increment: A market of impaired peripheral blood flow in diabetic neuropathy Diabetologia 35 1992 155
269. S. Tesfaye R. Malik J.D. Ward Vascular factors in diabetic neuropathy Diabetologia 37 1994 847 854
270. The DCCT Research Group Epidemiology of severe hypoglycemia in the diabetes control and complications trial Am J Med 90 1991 450 459
271. The Diabetes Control and Complications Trial Research Group The effect of intensive diabetes therapy on the development and progression of neuropathy Ann Intern Med 122 1995 561 568
272. P.K. Thomas D.R. Tomlinson Diabetic and hypoglycemic neuropathy P.K. Dyck P.K. Thomas J.W. Griffin Peripheral Neuropathy 1993 WB Saunders Philadelphia
273. P.K. Thomas Growth factors and diabetic neuropathy Diabetic Med 11 1994 732 739
274. J.H. Thurston D.B. McDougal Jr R.E. Hauhart Effects of acute, subacute, and chronic diabetes on carbohydrate and energy metabolism in rat sciatic nerve: Relation to mechanisms of peripheral neuropathy Diabetes 44 1995 190 195
275. R.G. Tilton K. Chang K.H. Hasan Prevention of diabetic vascular dysfunction by guanidines: Inhibition of nitric oxide synthase versus advanced glycation end-product formation Diabetes 42 1993 221 232
276. D.R. Tomlinson Polyols and myoinositol in diabetic neuropathy—of mice and men Mayo Clin Proc 64 1989 1030
277. M.E. Trulson J.H. Jacoby R.G. MacKenzie Streptozocin-induced diabetes reduces brain serotonin synthesis in rats J Neurochem 46 1986 1068 1072
278. P.A. Tun D.M. Nathan L.C. Perlmutter Cognitive and affective disorders in elderly diabetics Clin Geriatr Med 6 1990 731 746
279. P.A. Tun L.C. Perlmutter P. Russo Memory self-assessment and performance in aged diabetics and non-diabetics Exp Aging Res 13 1987 151 157
280. W.M.G. Tunbridge Factors contributing to deaths of diabetics under fifty years of age Lancet 2 1981 569 572
281. L. Uccioli G. Monticone F. Russo Autonomic neuropathy and transcutaneous oxymetry in diabetic lower extremities Diabetologia 37 1994 1051 1055
282. J.A. Van der Meulen A. Klip S. Grinstein Possible mechanism for cerebral oedema in diabetic ketoacidosis Lancet 2 1987 306 308
283. J.M. van Gervan A.M. Tjon-A-Tsien The efficacy of aldose reductase inhibitors in the management of diabetic complications: Comparison with intensive insulin treatment and pancreatic transplantation Drugs Aging 6 1995 9 28
284. A. Veves M.J. Young C. Manes Differences in peripheral and autonomic nerve function measurements in painful and painless neuropathy: A clinical study Diabetes Care 17 1994 1200 1202
285. A.I. Vinik M.T. Holland J.M. LeBeau Diabetic neuropathies Diabetes Care 15 1992 1926 1975
286. H. Vlassara Cell-mediated interaction of advanced glycosylation end products and the vascular wall N. Ruderman J. Williamson M. Brownlee Hyperglycemia, Diabetes, and Vascular Disease 1992 Oxford University Press New York 228
287. K.R. Wagner R.E. Myers Hyperglycemia preserves brain mitochondrial respiration during anoxia J Neurochem 47 1986 1620 1626
288. P.J. Watkins Natural history of the diabetic neuropathies QJ Med 77 1990 1209 1218
289. Weber AB, Jacob RJ, Stuart P, et al: Moderate hypoglycemia impairs the function of the inferior colliculus in the awake rat. Metabolism 43:1329-1331
290. T.J. Weiman V.G. Patel Treatment of hyperesthetic neuropathic pain in diabetics: Decompression of the tarsal tunnel Ann Surg 221 1995 660 665
291. T. Wieloch Hypoglycemia-induced neuronal damage prevented by an N-methyl-D-asparate antagonist Science 230 1985 681 683
292. J.R. Williamson K. Chang W. Allison Endoneurial blood flow changes in diabetic rats Diabetic Med 10 suppl 2 1993 49S 51S
293. T.D. Wilton Tegretol in the treatment of diabetic neuropathy S Afr Med J 48 1974 869
294. S.P. Wolff Transition metals and oxidative stress in the complications of diabetes F.A. Gries K. Wessels The Role of Anti-oxidants in Diabetes Mellitus 1993 pmi Verlagsgruppe Frankfurt am Main 81 101
295. R. Wredling S. Levander U. Adamson Permanent neuropsychological impairment after recurrent episodes of severe hypoglycaemia in man Diabetologia 33 1990 512 557
296. R.J. Wurtman F. Larin S. Mostafapour Brain catechol synthesis: Control by brain tyrosine concentration Science 185 1974 183 184
297. S. Yagihashi M. Kamijo M. Baba Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats Diabetes 41 1992 47
298. M.A. Zasslow R.G. Pearl L.M. Shuer Hyperglycemia decreases acute neuronal ischemic change after middle cerebral artery occlusion in cats Stroke 20 1989 519 523
299. D. Ziegler P. Mayer W. Rathmann One-year treatment with the aldose reductase inhibitor, ponalrestat, in diabetic neuropathy Diabetes Res Clin Pract 4 1991 67 75